BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29505586)

  • 1. A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.
    Richie DL; Wang L; Chan H; De Pascale G; Six DA; Wei JR; Dean CR
    PLoS One; 2018; 13(3):e0193851. PubMed ID: 29505586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LpxK Is Essential for Growth of
    Wei JR; Richie DL; Mostafavi M; Metzger LE; Rath CM; Sawyer WS; Takeoka KT; Dean CR
    mSphere; 2017; 2(4):. PubMed ID: 28815210
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.
    Richie DL; Takeoka KT; Bojkovic J; Metzger LE; Rath CM; Sawyer WS; Wei JR; Dean CR
    PLoS One; 2016; 11(8):e0160918. PubMed ID: 27526195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.
    Bojkovic J; Richie DL; Six DA; Rath CM; Sawyer WS; Hu Q; Dean CR
    J Bacteriol; 2015 Dec; 198(4):731-41. PubMed ID: 26668262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunflower (Helianthus annuus) fatty acid synthase complex: enoyl-[acyl carrier protein]-reductase genes.
    González-Thuillier I; Venegas-Calerón M; Garcés R; von Wettstein-Knowles P; Martínez-Force E
    Planta; 2015 Jan; 241(1):43-56. PubMed ID: 25204631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1996 Jan; 271(4):1833-6. PubMed ID: 8567624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
    Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
    J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Acinetobacter baumannii fatty acid synthesis 3-oxoacyl-ACP reductases.
    Cross EM; Adams FG; Waters JK; Aragão D; Eijkelkamp BA; Forwood JK
    Sci Rep; 2021 Mar; 11(1):7050. PubMed ID: 33782435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of FabG and FabI of the Streptomyces coelicolor dissociated fatty acid synthase.
    Singh R; Reynolds KA
    Chembiochem; 2015 Mar; 16(4):631-40. PubMed ID: 25662938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
    Dong H; Cronan JE
    Mol Microbiol; 2022 Nov; 118(5):541-551. PubMed ID: 36100979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria.
    Zhou P; Hong J
    Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin.
    McClerren AL; Endsley S; Bowman JL; Andersen NH; Guan Z; Rudolph J; Raetz CR
    Biochemistry; 2005 Dec; 44(50):16574-83. PubMed ID: 16342948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Francisella tularensis FabI enoyl-acyl carrier protein reductase gene is essential to bacterial viability and is expressed during infection.
    Kingry LC; Cummings JE; Brookman KW; Bommineni GR; Tonge PJ; Slayden RA
    J Bacteriol; 2013 Jan; 195(2):351-8. PubMed ID: 23144254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of malonyl-CoA metabolism by acyl-acyl carrier protein and beta-ketoacyl-acyl carrier protein synthases in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Jun; 270(26):15531-8. PubMed ID: 7797547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel compounds against Acinetobacter baumannii 3-oxoacyl-[acyl-carrier-protein] synthase I (FabB) via comprehensive structure-based computational approaches.
    Albayrak E; Koçer S; Mutlu O
    J Mol Graph Model; 2023 Nov; 124():108565. PubMed ID: 37454410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase.
    Sharma S; Sharma SK; Modak R; Karmodiya K; Surolia N; Surolia A
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2552-8. PubMed ID: 17485508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.